Prognostic Model of Hypertension
Recruiting · NCT06160921 · Observational (researchers observe without assigning treatment) · Lead sponsor: Xinjiang Medical University
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
The aim of this study was to establish a registration and monitoring system for hypertension in Xinjiang from 2020 to 2030 to obtain real information about patient basic information, patient characteristics, diagnostic test patterns, treatment options, and hospitalization outcomes (including mortality). Treatment complications, hospitalization costs, and end-of-life events (death, major adverse cardiac events, mild adverse cardiovascular events) in patients with hypertension in Xinjiang; and scientific prevention strategies aimed at effectively preventing the onset of hypertension; Guidelines in clinical practice recommend, analyze and develop effective treatment strategies to optimize management and outcomes for patients with hypertension; and create cost-effective assessment systems.
Who can take part
Inclusion criteria
- A patient diagnosed with primary hypertension who was admitted to the First Affiliated Hospital of Xinjiang Medical University
Exclusion criteria
- Patients with secondary hypertension, patients with liver and kidney dysfunction,
- patients with mental disorders, and patients who are unwilling to participate in this trial
Where it is running
1 location listed.
- The First Affiliated Hospital of Xinjiang Medicial University - Ürümqi, Xinjiang, China